Dean Jared Auclair Featured in NGN News for Pioneering Work on AI and Drug-Safety Regulation
This week, Dean Jared Auclair was featured in Northeastern Global News for his groundbreaking approach to one of the most urgent questions in modern health care: How do we regulate AI in drug discovery without slowing lifesaving innovation?
In the NGN article, “AI could revolutionize drug discovery. But how can we regulate it?”, he discusses how artificial intelligence is transforming the development of new treatments—from cancer therapies to drugs for rare diseases—and the challenge of ensuring that regulations keep pace with these rapid advances.
Auclair and his co-authors have introduced the AI-enabled Ecosystem for Therapeutics (AI2ET), a new framework designed to unify fragmented global guidelines and provide a science-based, risk-based approach to regulating AI in health care. Rather than focusing on individual tools, AI2ET emphasizes the broader systems and processes that support safe, effective drug development.
The article also highlights Auclair’s call for more adaptable regulatory structures—potentially even new agencies—capable of overseeing the fast-moving intersection of biotechnology and artificial intelligence.
For current and prospective students, faculty, and staff, Auclair’s work reflects the College’s commitment to forward-thinking leadership and the responsible use of emerging technologies to improve lives.
